Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma.

American journal of hematology - 1 Sept 1997

Legare R D, Gribben J G, Maragh M, Hermanowski-Vosatka A, Roach S, Tantravahi R, Nadler L M, Gilliland D G

Abstract excerpt

Therapy-related acute myelogenous leukemia and myelodysplastic syndrome (t-AML/MDS) are being reported with increasing frequency as a complication of ABMT for Hodgkin's disease and non-Hodgkin's lymphoma. At present there is no method available to predict who is at risk or is destined to develop this nearly universally fatal disorder. We therefore investigated whether clonal growth of cells is predictive of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Bone Marrow Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myeloid, Acute

Share to Lymphoma

Share to Polymerase Chain Reaction

Share to Predictive Value of Tests

Share to Receptors, Androgen

Share to X Chromosome

Source

Identifiers

PMID: 9298868
DOI: 10.1002/(sici)1096-8652(199709)56:1<45::aid-ajh10>3.0.co;2-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma.PMID 9298868Read ↗

Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non- Hodgkin's lymphomaSemantic proximity Read ↗

Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012).Semantic proximity Read ↗

How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?Semantic proximity Read ↗

Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post–autologous stem cell transplantationSemantic proximity Read ↗

Influence of the Bone Marrow Microenvironment on Hematopoietic Stem Cell Behavior Post-Allogeneic Transplantation: Development of Clonal Hematopoiesis and Telomere Dynamics.Semantic proximity Read ↗

Evaluation of the risk of therapy-related MDS/AML after autologous stem cell transplantation.Semantic proximity Read ↗

Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant.Semantic proximity Read ↗

Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.